跳至主要内容
临床试验/NCT03373643
NCT03373643Unknown不适用

Association Between Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease Investigated by Liver Biopsy

University Hospital, Angers1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年12月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Association between OSA severity marker (apnea hypopnea index per hour on the polysomnography) and significant liver fibrosis (score F3 and F4 of the histological nonalcoholic steatohepatitis [NASH]-CRN classification)

研究概览

简要总结

Obstructive sleep apnea (OSA) and nonalcoholic fatty liver disease (NAFLD) are frequently encountered in patients with metabolic syndrome (MS). Several data suggest that OSA per se could be a risk factor of liver injury. Most previous studies evaluating the association between OSA severity and the severity of NAFLD used indirect markers of NAFLD including liver imaging or liver injury blood markers or have been performed in morbidly obese patients undergoing intraoperative needle liver biopsy during bariatric surgery.

The current study propose to investigate with a full night polysomnography consecutive patients undergoing percutaneous liver biopsy for suspected NAFLD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Suspected NAFLD requiring per-cutaneous liver biopsy

排除标准

  • •Other than NAFLD liver disease
  • •Previously diagnosed or treated OSA
  • •Excessive alcohol consumption (>220 gr/week for men, >140 gr/week for women)
  • •Pregnancy
  • •Surgical treatment for obesity past history

研究组 & 干预措施

Patient suspected for NAFLD

Experimental

干预措施: OSA screening (Diagnostic Test)

结局指标

主要结局

Association between OSA severity marker (apnea hypopnea index per hour on the polysomnography) and significant liver fibrosis (score F3 and F4 of the histological nonalcoholic steatohepatitis [NASH]-CRN classification)

时间窗: The polysomnography will be performed no more than 3 months after the liver biopsy.

Apnea hypopnea index per hour of sleep is investigated in each participant using full night polysomnography. Significant liver fibrosis will be considered if histological analysis conclude to a fibrosis score of 3 or more using the NASH-CRN classification (F3 and F4).

次要结局

  • Association between OSA severity marker (apnea hypopnea index per hour on the polysomnography) and significant nonalcoholic steatohepatitis (3 positive criteria on NASH-CRN classification)(The polysomnography will be performed no more than 3 months after the liver biopsy.)
  • Association between OSA severity marker (apnea hypopnea index per hour on the polysomnography) and significant liver steatosis (histological steatosis > 33% or stade 2 or more on NASH-CRN)(The polysomnography will be performed no more than 3 months after the liver biopsy.)

研究者

发起方
University Hospital, Angers
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验